186 related articles for article (PubMed ID: 15502480)
1. Concurrent use of 5% natamycin and 2% econazole for the management of fungal keratitis.
Prajna NV; Nirmalan PK; Mahalakshmi R; Lalitha P; Srinivasan M
Cornea; 2004 Nov; 23(8):793-6. PubMed ID: 15502480
[TBL] [Abstract][Full Text] [Related]
2. A randomised clinical trial comparing 2% econazole and 5% natamycin for the treatment of fungal keratitis.
Prajna NV; John RK; Nirmalan PK; Lalitha P; Srinivasan M
Br J Ophthalmol; 2003 Oct; 87(10):1235-7. PubMed ID: 14507756
[TBL] [Abstract][Full Text] [Related]
3. Voriconazole versus natamycin as primary treatment in fungal corneal ulcers.
Arora R; Gupta D; Goyal J; Kaur R
Clin Exp Ophthalmol; 2011 Jul; 39(5):434-40. PubMed ID: 21105974
[TBL] [Abstract][Full Text] [Related]
4. Comparison of natamycin and voriconazole for the treatment of fungal keratitis.
Prajna NV; Mascarenhas J; Krishnan T; Reddy PR; Prajna L; Srinivasan M; Vaitilingam CM; Hong KC; Lee SM; McLeod SD; Zegans ME; Porco TC; Lietman TM; Acharya NR
Arch Ophthalmol; 2010 Jun; 128(6):672-8. PubMed ID: 20547942
[TBL] [Abstract][Full Text] [Related]
5. The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole.
Prajna NV; Krishnan T; Mascarenhas J; Rajaraman R; Prajna L; Srinivasan M; Raghavan A; Oldenburg CE; Ray KJ; Zegans ME; McLeod SD; Porco TC; Acharya NR; Lietman TM;
JAMA Ophthalmol; 2013 Apr; 131(4):422-9. PubMed ID: 23710492
[TBL] [Abstract][Full Text] [Related]
6. Fungal keratitis after laser in situ keratomileusis: a case report.
Chung MS; Goldstein MH; Driebe WT; Schwartz B
Cornea; 2000 Mar; 19(2):236-7. PubMed ID: 10746458
[TBL] [Abstract][Full Text] [Related]
7. Re-appraisal of topical 1% voriconazole and 5% natamycin in the treatment of fungal keratitis in a randomised trial.
Sharma S; Das S; Virdi A; Fernandes M; Sahu SK; Kumar Koday N; Ali MH; Garg P; Motukupally SR
Br J Ophthalmol; 2015 Sep; 99(9):1190-5. PubMed ID: 25740805
[TBL] [Abstract][Full Text] [Related]
8. Association between in vitro susceptibility to natamycin and voriconazole and clinical outcomes in fungal keratitis.
Sun CQ; Lalitha P; Prajna NV; Karpagam R; Geetha M; O'Brien KS; Oldenburg CE; Ray KJ; McLeod SD; Acharya NR; Lietman TM;
Ophthalmology; 2014 Aug; 121(8):1495-500.e1. PubMed ID: 24746358
[TBL] [Abstract][Full Text] [Related]
9. Study of Pathogens of Fungal Keratitis and the Sensitivity of Pathogenic Fungi to Therapeutic Agents with the Disk Diffusion Method.
Wang L; Wang L; Han L; Yin W
Curr Eye Res; 2015; 40(11):1095-101. PubMed ID: 26268399
[TBL] [Abstract][Full Text] [Related]
10. Corneal Cross-linking as an Adjuvant Therapy in the Management of Recalcitrant Deep Stromal Fungal Keratitis: A Randomized Trial.
Uddaraju M; Mascarenhas J; Das MR; Radhakrishnan N; Keenan JD; Prajna L; Prajna VN
Am J Ophthalmol; 2015 Jul; 160(1):131-4.e5. PubMed ID: 25841317
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic response time of topical voriconazole 1% and intrastromal voriconazole 0.05% versus topical natamycin 5% monotherapy in Fusarium keratitis in rabbit.
Edwar L; Janna YM; Rozaliyani A; Louisa M
Mycoses; 2020 Oct; 63(10):1128-1132. PubMed ID: 32780874
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous bilateral fungal keratitis caused by different fungi.
Prajna NV; Rao RA; Mathen MM; Prajna L; George C; Srinivasan M
Indian J Ophthalmol; 2002 Sep; 50(3):213-4. PubMed ID: 12355697
[TBL] [Abstract][Full Text] [Related]
13. Medical management of Beauveria bassiana keratitis.
Kisla TA; Cu-Unjieng A; Sigler L; Sugar J
Cornea; 2000 May; 19(3):405-6. PubMed ID: 10832710
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for treatment outcome in fungal keratitis.
Lalitha P; Prajna NV; Kabra A; Mahadevan K; Srinivasan M
Ophthalmology; 2006 Apr; 113(4):526-30. PubMed ID: 16581414
[TBL] [Abstract][Full Text] [Related]
15. Scedosporium Keratitis: An Experience From a Tertiary Eye Hospital in South India.
Rathi HS; Venugopal A; Rengappa R; Ravindran M
Cornea; 2016 Dec; 35(12):1575-1577. PubMed ID: 27538191
[TBL] [Abstract][Full Text] [Related]
16. Fungal keratitis caused by
Dudeja L; Jeganathan L; Prajna NV; Prajna L
Indian J Med Microbiol; 2018; 36(1):140-142. PubMed ID: 29735846
[TBL] [Abstract][Full Text] [Related]
17. Vision-Related Quality-of-Life Outcomes in the Mycotic Ulcer Treatment Trial I: A Randomized Clinical Trial.
Rose-Nussbaumer J; Prajna NV; Krishnan KT; Mascarenhas J; Rajaraman R; Srinivasan M; Raghavan A; Oldenburg CE; O'Brien KS; Ray KJ; McLeod SD; Porco TC; Lietman TM; Acharya NR; Keenan JD;
JAMA Ophthalmol; 2015 Jun; 133(6):642-6. PubMed ID: 25764482
[TBL] [Abstract][Full Text] [Related]
18. Fungal keratitis caused by Scopulariopsis brevicaulis treated successfully with natamycin.
Malecha MA
Cornea; 2004 Mar; 23(2):201-3. PubMed ID: 15075891
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of topical versus intrastromal voriconazole as an adjunct to natamycin in recalcitrant fungal keratitis.
Sharma N; Chacko J; Velpandian T; Titiyal JS; Sinha R; Satpathy G; Tandon R; Vajpayee RB
Ophthalmology; 2013 Apr; 120(4):677-81. PubMed ID: 23246119
[TBL] [Abstract][Full Text] [Related]
20. Clinical response of contact lens-associated fungal keratitis to topical fluoroquinolone therapy.
Munir WM; Rosenfeld SI; Udell I; Miller D; Karp CL; Alfonso EC
Cornea; 2007 Jun; 26(5):621-4. PubMed ID: 17525664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
